Copyright Reports & Markets. All rights reserved.

Global Capmatinib Hydrochloride Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Capmatinib Hydrochloride Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Genetically Mutated Population
    • 1.3.3 Advanced or Metastatic Patients
  • 1.4 Market Analysis by Specification
    • 1.4.1 Overview: Global Capmatinib Hydrochloride Tablets Consumption Value by Specification: 2021 Versus 2025 Versus 2032
    • 1.4.2 150 mg/Tablet
    • 1.4.3 200 mg/Tablet
  • 1.5 Market Analysis by Production Technology
    • 1.5.1 Overview: Global Capmatinib Hydrochloride Tablets Consumption Value by Production Technology: 2021 Versus 2025 Versus 2032
    • 1.5.2 Innovator
    • 1.5.3 Originator
  • 1.6 Market Analysis by Dosage Form
    • 1.6.1 Overview: Global Capmatinib Hydrochloride Tablets Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
    • 1.6.2 Tablet
    • 1.6.3 Film-coated Tablet
  • 1.7 Market Analysis by Application
    • 1.7.1 Overview: Global Capmatinib Hydrochloride Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 Non-Small Cell Lung Cancer (NSCLC)
    • 1.7.3 MET Exon 14 Skipping Mutation-Positive Patients
    • 1.7.4 Advanced or Metastatic Lung Cancer
    • 1.7.5 Others
  • 1.8 Global Capmatinib Hydrochloride Tablets Market Size & Forecast
    • 1.8.1 Global Capmatinib Hydrochloride Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.8.2 Global Capmatinib Hydrochloride Tablets Sales Quantity (2021-2032)
    • 1.8.3 Global Capmatinib Hydrochloride Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Capmatinib Hydrochloride Tablets Product and Services
    • 2.1.4 Novartis Capmatinib Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Novartis Recent Developments/Updates
  • 2.2 Incyte
    • 2.2.1 Incyte Details
    • 2.2.2 Incyte Major Business
    • 2.2.3 Incyte Capmatinib Hydrochloride Tablets Product and Services
    • 2.2.4 Incyte Capmatinib Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Incyte Recent Developments/Updates
  • 2.3 Sinoway Industrial
    • 2.3.1 Sinoway Industrial Details
    • 2.3.2 Sinoway Industrial Major Business
    • 2.3.3 Sinoway Industrial Capmatinib Hydrochloride Tablets Product and Services
    • 2.3.4 Sinoway Industrial Capmatinib Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sinoway Industrial Recent Developments/Updates
  • 2.4 Simson Pharma Limited
    • 2.4.1 Simson Pharma Limited Details
    • 2.4.2 Simson Pharma Limited Major Business
    • 2.4.3 Simson Pharma Limited Capmatinib Hydrochloride Tablets Product and Services
    • 2.4.4 Simson Pharma Limited Capmatinib Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Simson Pharma Limited Recent Developments/Updates
  • 2.5 Hangzhou Jinlan Pharm-Drugs Technology
    • 2.5.1 Hangzhou Jinlan Pharm-Drugs Technology Details
    • 2.5.2 Hangzhou Jinlan Pharm-Drugs Technology Major Business
    • 2.5.3 Hangzhou Jinlan Pharm-Drugs Technology Capmatinib Hydrochloride Tablets Product and Services
    • 2.5.4 Hangzhou Jinlan Pharm-Drugs Technology Capmatinib Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Hangzhou Jinlan Pharm-Drugs Technology Recent Developments/Updates
  • 2.6 Dingwang Technology
    • 2.6.1 Dingwang Technology Details
    • 2.6.2 Dingwang Technology Major Business
    • 2.6.3 Dingwang Technology Capmatinib Hydrochloride Tablets Product and Services
    • 2.6.4 Dingwang Technology Capmatinib Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Dingwang Technology Recent Developments/Updates
  • 2.7 Beijing SJAR Technology Development
    • 2.7.1 Beijing SJAR Technology Development Details
    • 2.7.2 Beijing SJAR Technology Development Major Business
    • 2.7.3 Beijing SJAR Technology Development Capmatinib Hydrochloride Tablets Product and Services
    • 2.7.4 Beijing SJAR Technology Development Capmatinib Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Beijing SJAR Technology Development Recent Developments/Updates

3 Competitive Environment: Capmatinib Hydrochloride Tablets by Manufacturer

  • 3.1 Global Capmatinib Hydrochloride Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Capmatinib Hydrochloride Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Capmatinib Hydrochloride Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Capmatinib Hydrochloride Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Capmatinib Hydrochloride Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Capmatinib Hydrochloride Tablets Manufacturer Market Share in 2025
  • 3.5 Capmatinib Hydrochloride Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Capmatinib Hydrochloride Tablets Market: Region Footprint
    • 3.5.2 Capmatinib Hydrochloride Tablets Market: Company Product Type Footprint
    • 3.5.3 Capmatinib Hydrochloride Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Capmatinib Hydrochloride Tablets Market Size by Region
    • 4.1.1 Global Capmatinib Hydrochloride Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Capmatinib Hydrochloride Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Capmatinib Hydrochloride Tablets Average Price by Region (2021-2032)
  • 4.2 North America Capmatinib Hydrochloride Tablets Consumption Value (2021-2032)
  • 4.3 Europe Capmatinib Hydrochloride Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Capmatinib Hydrochloride Tablets Consumption Value (2021-2032)
  • 4.5 South America Capmatinib Hydrochloride Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Capmatinib Hydrochloride Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Capmatinib Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Capmatinib Hydrochloride Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Capmatinib Hydrochloride Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Capmatinib Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Capmatinib Hydrochloride Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Capmatinib Hydrochloride Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Capmatinib Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Capmatinib Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Capmatinib Hydrochloride Tablets Market Size by Country
    • 7.3.1 North America Capmatinib Hydrochloride Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Capmatinib Hydrochloride Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Capmatinib Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Capmatinib Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Capmatinib Hydrochloride Tablets Market Size by Country
    • 8.3.1 Europe Capmatinib Hydrochloride Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Capmatinib Hydrochloride Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Capmatinib Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Capmatinib Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Capmatinib Hydrochloride Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Capmatinib Hydrochloride Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Capmatinib Hydrochloride Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Capmatinib Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Capmatinib Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Capmatinib Hydrochloride Tablets Market Size by Country
    • 10.3.1 South America Capmatinib Hydrochloride Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Capmatinib Hydrochloride Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Capmatinib Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Capmatinib Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Capmatinib Hydrochloride Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Capmatinib Hydrochloride Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Capmatinib Hydrochloride Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Capmatinib Hydrochloride Tablets Market Drivers
  • 12.2 Capmatinib Hydrochloride Tablets Market Restraints
  • 12.3 Capmatinib Hydrochloride Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Capmatinib Hydrochloride Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Capmatinib Hydrochloride Tablets
  • 13.3 Capmatinib Hydrochloride Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Capmatinib Hydrochloride Tablets Typical Distributors
  • 14.3 Capmatinib Hydrochloride Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Capmatinib Hydrochloride Tablets market size was valued at US$ 185 million in 2025 and is forecast to a readjusted size of US$ 1195 million by 2032 with a CAGR of 12.6% during review period.
    In 2025, global Capmatinib Hydrochloride Tablets production reached approximately 180,000 units.Capmatinib Hydrochloride Tablets are a highly selective mesenchymal–epithelial transition (MET) receptor tyrosine kinase inhibitor and belong to small-molecule oral targeted anticancer drugs. They primarily act by inhibiting the abnormal activation of the MET signaling pathway, thereby blocking tumor cell proliferation, migration, and survival, and play an important role in precision oncology. This drug is mainly used for the treatment of patients with non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations. It is characterized by strong target specificity, proven efficacy, and convenient oral administration, and represents an important therapeutic option in the field of MET-targeted therapies.
    Capmatinib Hydrochloride Tablets, as a precision targeted anticancer drug acting on the MET signaling pathway, occupy an important position in the segmented treatment market for non-small cell lung cancer (NSCLC). With the increasing adoption of genetic testing and improved identification of patients with MET exon 14 skipping mutations, the target patient population is gradually expanding, driving steady growth in market demand. Meanwhile, under the trend of precision medicine and personalized therapy, the clinical value of MET inhibitors continues to become more prominent. However, market competition is also intensifying, including from similar MET inhibitors such as Tepotinib as well as other targeted therapies, which pose certain pressures on its market share. Overall, the market for Capmatinib Hydrochloride Tablets represents a “high-value, small-population” niche, with future growth mainly driven by increased diagnostic penetration, expansion of indications, and global market development.
    This report is a detailed and comprehensive analysis for global Capmatinib Hydrochloride Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Capmatinib Hydrochloride Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Capmatinib Hydrochloride Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Capmatinib Hydrochloride Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Capmatinib Hydrochloride Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Capmatinib Hydrochloride Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Capmatinib Hydrochloride Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Incyte, Sinoway Industrial, Simson Pharma Limited, Hangzhou Jinlan Pharm-Drugs Technology, Dingwang Technology, Beijing SJAR Technology Development, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Capmatinib Hydrochloride Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Genetically Mutated Population
    Advanced or Metastatic Patients
    Market segment by Specification
    150 mg/Tablet
    200 mg/Tablet
    Market segment by Production Technology
    Innovator
    Originator
    Market segment by Dosage Form
    Tablet
    Film-coated Tablet
    Market segment by Application
    Non-Small Cell Lung Cancer (NSCLC)
    MET Exon 14 Skipping Mutation-Positive Patients
    Advanced or Metastatic Lung Cancer
    Others
    Major players covered
    Novartis
    Incyte
    Sinoway Industrial
    Simson Pharma Limited
    Hangzhou Jinlan Pharm-Drugs Technology
    Dingwang Technology
    Beijing SJAR Technology Development
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Capmatinib Hydrochloride Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Capmatinib Hydrochloride Tablets, with price, sales quantity, revenue, and global market share of Capmatinib Hydrochloride Tablets from 2021 to 2026.
    Chapter 3, the Capmatinib Hydrochloride Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Capmatinib Hydrochloride Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Capmatinib Hydrochloride Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Capmatinib Hydrochloride Tablets.
    Chapter 14 and 15, to describe Capmatinib Hydrochloride Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now